angiotensin ii has been researched along with verlukast in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ertl, G; Gaudron, P; Han, H; Hu, K; Neubauer, S; Tian, R | 1 |
Bedouch, P; Bessard, G; Chavanon, O; Cracowski, JL; Devillier, P; Stanke-Labesque, F | 1 |
Gopalakrishnan, V; Kaul, C; McNeill, JR; Poduri, R; Shastri, S; Wilson, TW | 1 |
Bessard, G; Caron, F; Devillier, P; Faure, P; Hakim, A; Halimi, S; Hardy, G; Morel, S; Peoc'h, M; Stanke-Labesque, F | 1 |
Gopalakrishnan, V; Liu, P; Misurski, DA | 1 |
5 other study(ies) available for angiotensin ii and verlukast
Article | Year |
---|---|
Effects of LTD4 and its specific antagonist L-660,711 in isolated rat hearts with chronic myocardial infarction.
Topics: Angiotensin I; Angiotensin II; Animals; Body Weight; Bronchodilator Agents; Coronary Circulation; Heart; Heart Rate; In Vitro Techniques; Leukotriene D4; Male; Myocardial Infarction; Organ Size; Propionates; Quinolines; Rats; Rats, Wistar; Time Factors; Ventricular Function, Left | 1994 |
Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Angiotensin II; Benzoquinones; Biphenyl Compounds; Cyclooxygenase Inhibitors; Depression, Chemical; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavanones; Flavonoids; Heptanoic Acids; Humans; Imidazoles; In Vitro Techniques; Indomethacin; Leukotrienes; Lipoxygenase Inhibitors; Mammary Arteries; Propionates; Pyrazoles; Quinolines; Receptors, Thromboxane; Substance P; Thromboxane B2; Thromboxane-A Synthase; Vasoconstriction | 2000 |
Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR.
Topics: Angiotensin II; Animals; Benzoquinones; Endothelin-1; Hypertension; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Male; Potassium Chloride; Propionates; Quinolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Splanchnic Circulation; Vasoconstriction | 2001 |
Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic rats.
Topics: Angiotensin II; Animals; Aorta; Benzoquinones; Diabetes Mellitus, Experimental; Insulin; Leukotriene Antagonists; Leukotriene E4; Lipoxygenase Inhibitors; Male; Organ Culture Techniques; Potassium Chloride; Propionates; Quinolines; Rats; Rats, Wistar; SRS-A; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Cysteinyl leukotriene-dependent [Ca2+]i responses to angiotensin II in cardiomyocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Arginine Vasopressin; Benzoquinones; Calcium; Cysteine; Endothelin-1; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Heart; Imidazoles; Inositol 1,4,5-Trisphosphate; Leukotriene C4; Leukotriene D4; Leukotrienes; Lipoxygenase Inhibitors; Losartan; Myocardium; Propionates; Pyridines; Quinolines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Spectrometry, Fluorescence | 2003 |